A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Gilead Sciences
ImmunityBio, Inc.
OHSU Knight Cancer Institute
Celgene
Asan Medical Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Centre de recherche du Centre hospitalier universitaire de Sherbrooke